Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.
about
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazoneThe Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice.Can the electrophysiological action of rosiglitazone explain its cardiac side effects?Idealized PPARγ-Based Therapies: Lessons from Bench and Bedsidep-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes.Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes.Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing.Rosiglitazone induces cardiotoxicity by accelerated apoptosis.Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats.Protective effects of desacyl ghrelin on diabetic cardiomyopathy.TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells.
P2860
Q35005657-1D55D25A-EB85-4F75-B081-BE4C498E9FB2Q35100131-944D7414-E93A-405B-84FF-04AE6459E14DQ35889770-06480B64-27E8-43EB-A348-960EBB49F6FDQ36032128-A3F5B997-BC6E-420E-BE53-0E586B6DE42DQ36056207-8069D646-3D73-4065-9286-E287993E94A4Q36141979-14BA8B08-0F79-4D1D-AD18-C7E3F3070851Q37463334-CAC5A54C-B582-496F-8657-2B26A2B0F438Q37685967-05106070-EC68-4545-86B7-1C10C0BCD224Q38083574-91FE6F0B-5067-4C77-81C9-06B51146E7E2Q38476306-AA47780D-70AB-43C8-88A5-16E7FD3A723FQ38637752-D1797787-C64B-456A-BD5A-9C9B19E1F410Q39061512-171CEDCB-8726-4419-8B3A-D29995390BEFQ42701033-C13BF9FB-EBD6-48E9-9877-C051FF6532E0Q51793866-FFC882D4-4342-4599-BDED-A753DF69CE41Q54336492-124D7300-D94A-477F-89AF-02B675057A79
P2860
Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Transcriptome alteration in th ...... for cardiovascular mortality.
@ast
Transcriptome alteration in th ...... for cardiovascular mortality.
@en
type
label
Transcriptome alteration in th ...... for cardiovascular mortality.
@ast
Transcriptome alteration in th ...... for cardiovascular mortality.
@en
prefLabel
Transcriptome alteration in th ...... for cardiovascular mortality.
@ast
Transcriptome alteration in th ...... for cardiovascular mortality.
@en
P2093
P2860
P50
P1433
P1476
Transcriptome alteration in th ...... for cardiovascular mortality.
@en
P2093
David L Hirschberg
Patrick Yue
Paul G Yock
Phillip Tsao
Roger Wagner
P2860
P356
10.1371/JOURNAL.PONE.0002609
P407
P577
2008-07-09T00:00:00Z